HKD 7.66
(-1.42%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 89.5 Million USD | 120.13% |
2022 | 40.65 Million USD | 843.8% |
2021 | 4.3 Million USD | -69.46% |
2020 | 14.1 Million USD | 160.32% |
2019 | 5.41 Million USD | 265.41% |
2018 | 1.48 Million USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 11.85 Million USD | -51.14% |
2024 Q2 | 11.85 Million USD | 0.0% |
2023 Q4 | 24.25 Million USD | 0.0% |
2023 Q2 | 20.49 Million USD | 0.0% |
2023 Q3 | 24.25 Million USD | 18.32% |
2023 FY | 89.5 Million USD | 120.13% |
2023 Q1 | 20.49 Million USD | 214.65% |
2022 FY | 40.65 Million USD | 843.8% |
2022 Q4 | 6.51 Million USD | 0.0% |
2022 Q3 | 6.51 Million USD | -52.84% |
2022 Q2 | 13.81 Million USD | 0.0% |
2022 Q1 | 13.81 Million USD | 1218.23% |
2021 Q4 | 1.04 Million USD | 0.0% |
2021 Q3 | 1.04 Million USD | -5.24% |
2021 Q1 | 1.1 Million USD | -72.48% |
2021 FY | 4.3 Million USD | -69.46% |
2021 Q2 | 1.1 Million USD | 0.0% |
2020 Q4 | 4.01 Million USD | 0.0% |
2020 Q2 | 3.03 Million USD | 0.0% |
2020 Q1 | 3.03 Million USD | 24.82% |
2020 FY | 14.1 Million USD | 160.32% |
2020 Q3 | 4.01 Million USD | 32.41% |
2019 Q3 | 2.43 Million USD | 774.64% |
2019 FY | 5.41 Million USD | 265.41% |
2019 Q4 | 2.43 Million USD | 0.0% |
2019 Q2 | 278 Thousand USD | 0.0% |
2019 Q1 | 278 Thousand USD | 0.0% |
2018 FY | 1.48 Million USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Uni-Bio Science Group Limited | 484.71 Million HKD | 81.535% |
CK Life Sciences Int'l., (Holdings) Inc. | 5.32 Billion HKD | 98.318% |